+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton pump inhibitors relieve and prevent symptoms related to gastric acidity after esophagectomy

Proton pump inhibitors relieve and prevent symptoms related to gastric acidity after esophagectomy

World Journal of Surgery 32(2): 246-254

Denervated stomach used as an esophageal substitute after esophagectomy often retains or spontaneously recovers acid production. The aims of the present study were to assess the relationship between esophageal acid exposure or gastric acidity and reflux-related symptoms after esophagectomy, and to assess the ability of proton pump inhibitors (PPIs) to relieve gastroesophageal reflux-related symptoms. Forty-four patients underwent esophageal and gastric 24-h pH monitoring early after esophagectomy with gastric reconstruction. Initially, patients with both gastric acidity and reflux symptoms were treated with PPIs (Treatment group), then all patients with gastric acidity, whether symptomatic or not, were treated (Prevention group). Reflux-related symptoms were correlated with esophageal acid exposure and postoperative gastric acidity. Gastric acidity was then correlated with serum anti-Helicobacter pylori immunoglobulin G (IgG) titers and preoperative endoscopic findings Sixteen patients (36.4%) reporting reflux and showing gastric acid production were treated with PPIs, which provided relief to 13 (81.3%). Although symptoms did not correlate with the esophageal acid exposure, postoperative gastric acidity was significantly greater among patients who were symptomatic than among those who were not. Overall, acid production was lower in older patients (>64 years of age), although older patients who were H. pylori-negative and without chronic atrophic gastritis also showed high levels of gastric acidity. Proton pump inhibitors should be administered prophylactically early after esophagectomy to relieve and prevent reflux-related symptoms. Candidates for preventive therapy include those less than 64 years of age or older patients who are H. pylori-negative and without chronic atrophic gastritis.

(PDF emailed within 0-6 h: $19.90)

Accession: 055260393

Download citation: RISBibTeXText

PMID: 18064513

DOI: 10.1007/s00268-007-9325-7

Related references

Proton pump inhibitors in IPF: beyond mere suppression of gastric acidity. Qjm 109(9): 577-579, 2017

Proton pump inhibitors should be taken with meals for optimal control of gastric acidity. Gastroenterology 114(4 PART 2): A144-A145, April 15, 1998

Review article: gastric acidity--comparison of esomeprazole with other proton pump inhibitors. Alimentary Pharmacology and Therapeutics 17 Suppl 1: 10-5; Discussion 16-7, 2003

Proton pump inhibitors reduce the size and acidity of the gastric Acid pocket. Journal of Neurogastroenterology and Motility 21(1): 133-134, 2015

Prevention of stress induced ulcers: histamine-2 receptor antagonists or proton pump inhibitors? - gastric hemorrhage occur more often under proton pump inhibitors. Deutsche Medizinische Wochenschrift 139(25-26): 1338, 2014

Impact of proton pump inhibitors on benign anastomotic stricture formations after esophagectomy and gastric tube reconstruction: results from a randomized clinical trial. Annals of Surgery 250(5): 667-673, 2009

The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors. Digestion 96(1): 52-59, 2017

Are persistent throat symptoms atypical features of gastric reflux and should they be treated with proton pump inhibitors?. Bmj 349: G5813, 2015

Proton-pump inhibitors for gastric acid-related disease. Cleveland Clinic Journal of Medicine 65(1): 27-34, 1998

Revealing the Mechanistic Pathway of Acid Activation of Proton Pump Inhibitors To Inhibit the Gastric Proton Pump: A DFT Study. Journal of Physical Chemistry. B 120(51): 13031-13038, 2016

Determination of the reduction in gastric acidity necessary to prevent pathological oesophageal reflux in patients with gastro-oesophageal reflux disease treated with a proton pump inhibitor. Alimentary Pharmacology & Therapeutics 17(7): 955-964, 1st April, 2003

Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study. Journal of Gastroenterology 2019, 2019

Proton-pump inhibitors and increased gastric cancer risk: time-related biases. Gut 67(12): 2228-2229, 2018

Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea?. Antimicrobial Agents and ChemoTherapy 51(8): 2883-2887, 2007

Nocturnal gastric acidity and nocturnal esophageal acidity are lower with immediate-release omeprazole than with lansoprazole or esomeprazole in GERD patients treated with a proton pump inhibitor. American Journal of Gastroenterology 102(Suppl. 2): S119-S120, 2007